CytoDyn (CYDY) News Today $0.32 0.00 (-1.01%) As of 07/11/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock CYDY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period CytoDyn (OTCMKTS:CYDY) Stock Price Down 1% - Time to Sell?July 12 at 2:57 AM | marketbeat.comCytoDyn Inc. (CYDY) Latest Stock News & Headlines - Yahoo FinanceJuly 1, 2025 | ca.finance.yahoo.comCytoDyn Announces Encouraging Survival Data in Patients with Metastatic Colorectal Cancer Previously Treated with LeronlimabJuly 1, 2025 | globenewswire.comCytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal CancerJune 24, 2025 | globenewswire.comCytoDyn (OTCMKTS:CYDY) Shares Down 2.8% - Here's What HappenedJune 20, 2025 | marketbeat.comCytoDyn (OTCMKTS:CYDY) Shares Down 2.3% - Here's What HappenedJune 1, 2025 | marketbeat.comCytoDyn Announces New Data Suggesting Novel Mechanism Of Action Of Leronlimab In Solid TumorsMay 15, 2025 | nasdaq.comCytoDyn Releases ESMO Breast Cancer Meeting PosterMay 15, 2025 | globenewswire.comCytoDyn's new data shows leronlimab could treat solid tumorsMay 13, 2025 | msn.comCytoDyn highlights potential of lead drug against solid tumors with new dataMay 13, 2025 | seekingalpha.comCytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid TumorsMay 13, 2025 | globenewswire.comCytoDyn Inc.: CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial OfficerMay 6, 2025 | finanznachrichten.deCytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial OfficerMay 6, 2025 | globenewswire.comCytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, GermanyApril 29, 2025 | globenewswire.comCytoDyn (OTCMKTS:CYDY) Stock Price Passes Below 50 Day Moving Average - What's Next?April 20, 2025 | marketbeat.comCytoDyn (OTCMKTS:CYDY) Share Price Crosses Above 50-Day Moving Average - Here's WhyApril 6, 2025 | marketbeat.comCytoDyn (OTCMKTS:CYDY) Shares Cross Below 50-Day Moving Average - What's Next?March 29, 2025 | marketbeat.comCytoDyn Inc (296.SG)March 27, 2025 | finance.yahoo.comCytoDyn (OTCMKTS:CYDY) Share Price Passes Below Fifty Day Moving Average - Here's WhyMarch 20, 2025 | marketbeat.comCytoDyn CEO writes March 2025 letter to shareholdersMarch 18, 2025 | markets.businessinsider.comCytoDyn Inc.: March 2025 Letter to ShareholdersMarch 18, 2025 | finanznachrichten.deMarch 2025 Letter to ShareholdersMarch 18, 2025 | globenewswire.comCytoDyn announces survival observations in mTNBC patientsFebruary 25, 2025 | markets.businessinsider.comCytoDyn Inc.: CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with LeronlimabFebruary 24, 2025 | finanznachrichten.deMicro Cap Surging On Company Developed CCR5 Antagonist Showing Promise In PatientsFebruary 24, 2025 | msn.comCytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with LeronlimabFebruary 24, 2025 | globenewswire.comCytoDyn Inc. (OTCMKTS:CYDY) Short Interest UpdateFebruary 17, 2025 | marketbeat.comCytoDyn Inc.: CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC LaboratoriesFebruary 6, 2025 | finanznachrichten.deCytoDyn Inc.: CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC LaboratoriesFebruary 6, 2025 | finanznachrichten.deCytoDyn announces results from preclinical studies with SMCFebruary 6, 2025 | markets.businessinsider.comCytoDyn announces results from preclinical studies with SMCFebruary 6, 2025 | markets.businessinsider.comCytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC LaboratoriesFebruary 6, 2025 | globenewswire.comShort Interest in CytoDyn Inc. (OTCMKTS:CYDY) Grows By 15.0%February 1, 2025 | marketbeat.comCytoDyn (OTCMKTS:CYDY) Trading 2.1% Higher - Here's WhyJanuary 3, 2025 | marketbeat.comCytoDyn Inc.: December 2024 Letter to ShareholdersDecember 17, 2024 | finanznachrichten.deDecember 2024 Letter to ShareholdersDecember 17, 2024 | globenewswire.comCytoDyn (OTCMKTS:CYDY) Stock Price Up 7.8% - Here's WhyDecember 13, 2024 | marketbeat.comCytoDyn Inc. (CYDY) Stock Price, News, Quote & History - Yahoo FinanceDecember 11, 2024 | finance.yahoo.comFormer Portland area biotech CEO is convicted in securities fraud schemeDecember 11, 2024 | bizjournals.comCytoDyn CEOs Caught in Fraud Scheme to Inflate Stock PricesDecember 11, 2024 | msn.comCytoDyn Appoints Richard Pestell, M.D., Ph.D. as Lead Consultant in OncologyNovember 25, 2024 | markets.businessinsider.comCytoDyn Inc. (OTCMKTS:CYDY) Sees Large Growth in Short InterestNovember 15, 2024 | marketbeat.comCytoDyn Announces FDA Clearance of Its Phase II Oncology TrialNovember 4, 2024 | globenewswire.comCytoDyn Appoints Dr. Melissa Palmer, M.D., as Lead Consultant in Hepatology; Announces Follow-Up Inflammation Studies with SMC LaboratoriesOctober 30, 2024 | globenewswire.comCytoDyn (OTCMKTS:CYDY) Shares Down 4% - Should You Sell?October 21, 2024 | marketbeat.comCytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical DevelopmentOctober 8, 2024 | finance.yahoo.comCytoDyn Announces Abstract that Highlights Leronlimab’s Potential in Mediating ART-Free Viral Control in Infant Rhesus MacaquesOctober 7, 2024 | finance.yahoo.comCytoDyn Announces Abstract that Highlights Leronlimab's Potential in Mediating ART-Free Viral Control in Infant Rhesus MacaquesOctober 7, 2024 | globenewswire.comCytoDyn Engages Syneos Health as CRO For Its Phase II Oncology TrialOctober 4, 2024 | globenewswire.comCytoDyn Announces Preliminary Findings in Study with SMC LaboratoriesSeptember 24, 2024 | globenewswire.com Get CytoDyn News Delivered to You Automatically Sign up to receive the latest news and ratings for CYDY and its competitors with MarketBeat's FREE daily newsletter. Email Address CYDY Media Mentions By Week CYDY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYDY News Sentiment▼0.000.99▲Average Medical News Sentiment CYDY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYDY Articles This Week▼11▲CYDY Articles Average Week Get CytoDyn News Delivered to You Automatically Sign up to receive the latest news and ratings for CYDY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EVO News Today VERA News Today ETNB News Today JANX News Today BHVN News Today ANIP News Today EVTCY News Today EWTX News Today TVTX News Today MESO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CYDY) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytoDyn Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytoDyn With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYDY Stock Alerts